Companies /Healthcare

Merck & Co Inc

NYSE: MRK Drug Manufacturers - General
$146.33
▲ $5.40 (+3.83%) today
Markets closed · 10:11pm ET

MRK Coverage Page 78

3:20am ET
Investing

Media Digest 7/3/2007 Reuters, WSJ, NYTimes, FT, Barron’s

According to Reuters, SAP (SAP) admitted that one of its divisions has inappropriately downloaded documents from rival Oracle (ORCL), but said the parent company never had access to them. Larry Ellison’s company,…

Douglas A. McIntyre
7:18am ET
Investing

Pre-Market Stock News (June 25, 2007)

(AAPL) Apple’s iTunes passed Amazon.com in music sales to become #3 music seller behind Best Buy and Wal-Mart.(AFOP) Alliance Fiber Optics raised Q2 sales guidance.(AGN) Allergan trades ex-split to reflect a 2-1…

Douglas A. McIntyre
4:37pm ET
Health and Healthcare

Biotech Implosion: Coley Pharmaceutical Group (COLY)

Shares of microcap biotech Coley Pharmaceutical Group (COLY-NASDAQ) saw shares get pounded late on Wednesday afternoon.  Right before 2:00 PM EST, the company announced that its partner Pfizer (PFE-NYSE) had discontinued and…

Douglas A. McIntyre
5:53pm ET
Health and Healthcare

Cramer’s Picks & Pans in Pharmaceuticals

Stock Tickers: MRK, PFE, JNJ, GSK, SGP, LLY, WYE, NVS, NVO On tonight’s MAD MONEY on CNBC, Jim Cramer said he keeps getting asked about Big Pharma drug stocks.  He’d rather focus…

Douglas A. McIntyre
6:30pm ET
Health and Healthcare

Biotechs & Pharmas Bracing For ASCO Annual Meeting

This weekend we have the mother of all future cancer treatment conferences: ASCO, or The American Society of Clinical Oncology.  Cancer stocks in the last few weeks have been seeing a muted…

Douglas A. McIntyre
5:25pm ET
Investing

DJIA Components Huge Rise in Short Selling (MAY-07)

We reviewed various short selling trends and noticed that most sectors were mixed to up as the April to May reached record levels.  But reviewing the 28 Dow Jones Industrial Average components…

Douglas A. McIntyre
4:36pm ET
Health and Healthcare

Short Selling Up in Drug & Medical Stocks

Some sectors showed mixed results in the short selling, but the Big Pharma and medical instruments and related companies saw an increased activity in short selling in May versus April.  Below is…

Douglas A. McIntyre